CRYOPORT, INC. Cash and Cash Equivalents
CRYOPORT, INC. (CYRX) had Cash and Cash Equivalents of $269.27 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $269.27M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $272.91M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $250.49M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $255.81M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $269.27M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $272.91M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $250.49M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $255.81M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $243.42M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $36.10M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $34.14M 10-Q · filed 2026-08-06 | $45.29M 10-K · filed 2025-03-07 |
| 2024-09-30 | $31.37M 10-Q · filed 2025-11-06 | $44.66M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $34.18M 10-Q · filed 2025-08-12 | $46.46M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $39.29M 10-Q · filed 2025-05-08 | $49.66M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $35.19M 10-K · filed 2026-03-05 | $46.35M 10-K · filed 2024-03-13 |
| 2023-09-30 | $59.47M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $67.31M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $38.54M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $29.23M 10-K · filed 2026-03-05 | $36.59M 10-K · filed 2023-02-28 |
| 2022-09-30 | $30.72M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $37.03M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $134.45M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $139.10M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $43.68M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $60.36M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $85.49M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $36.87M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $161.99M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $44.33M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $50.62M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $47.23M 10-K · filed 2021-03-01 | $47.23M 10-K · filed 2020-03-10 |
| 2019-09-30 | $44.59M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $80.64M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $32.77M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.33M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $13.85M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $20.01M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $18.99M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $15.04M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $15.40M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $12.85M 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $14.53M 10-Q · filed 2018-05-03 | |
| 2016-12-31 | $4.52M 10-K · filed 2019-03-13 | |
| 2016-09-30 | $2.56M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $4.53M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $2.79M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $5.25M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $7.06M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $2.39M 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $1.41M 10-KT · filed 2017-03-13 | |
| 2014-12-31 | $773.92K 10-Q · filed 2016-02-11 | |
| 2014-09-30 | $103.34K 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $170.50K 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $369.58K 10-K · filed 2016-06-28 | |
| 2013-12-31 | $219.97K 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $532.47K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $227.53K 10-Q · filed 2014-07-31 | |
| 2013-03-31 | $563.10K 10-K · filed 2015-05-19 | |
| 2012-12-31 | $585.11K 10-Q · filed 2014-02-13 | |
| 2012-09-30 | $1.67M 10-Q · filed 2013-11-18 | |
| 2012-06-30 | $2.97M 10-Q · filed 2013-08-14 | |
| 2012-03-31 | $4.62M 10-K · filed 2014-06-25 | |
| 2011-12-31 | $2.80M 10-Q · filed 2013-02-14 | |
| 2011-09-30 | $4.95M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $7.06M 10-Q · filed 2012-08-14 | |
| 2011-03-31 | $9.28M 10-K · filed 2013-06-25 | |
| 2010-12-31 | $2.71M 10-Q · filed 2012-02-21 | |
| 2010-09-30 | $3.75M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.10M 10-Q · filed 2011-08-15 | |
| 2010-03-31 | $3.63M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |